摘要
目的:探讨炎琥宁辅助治疗支原体肺炎的临床疗效。方法:根据我院门诊2008年2月~2010年2月收治的80例肺炎支原体肺炎患者的临床资料,随机分为:治疗组(40例)和对照组(40例),对照组患儿采用肺炎常规治疗方案,治疗组患者在常规治疗的基础上加用炎琥宁辅助治疗,比较两组患者的临床疗效以及药物的不良反应。结果:炎琥宁治疗儿童支原体肺炎效果明显,优于对照组,治疗组:有效果为22例,显著疗效为10例,无效果为8例,有效率达80%;对照组:有效果为17例,显著疗效为10例,无效果为13例,有效率67.5%,两组疗效差异有统计学意义(p<0.05)。两组患儿均未发生药物不良反应。结论:炎琥宁辅助治疗支原体肺炎,能减轻患儿的不适症状,疗效满意,值得在临床推广。
Goal: The discussion inflammation amber is rather auxiliary the treatment Mycoplasma pneumonia the clinical curative effect. Method: 80 example pneumonia Myceplasma pneumonia patient~ clinical material which in February, 2008 -2010 year in February admits according to my courtyard outpatient service, divides into stochastically: The treatment group (40 examples) and the control group (40 examples), the control group babies use pneumonia convention therapeutic schedule, the treatment group patients add in the conventional treatment foundation with the inflammation amber are rather auxiliary treat, compared with two group of patient~ clinical curative effects as well as medicine untoward effect. Finally: The inflammation amber rather treats the child Mycoplasma pneumonia effect to be obvious, surpasses the control group, the treatment group: Some effects are 22 examples, the remarkable curative effect is 10 examples, does not have the effect is 8 examples, effectiveness reaches 80% ; Control group: Some effects are 17 examrples, the remarkable curative effect is 10 examples, does not have the effect is 13 examples, effectiveness 67.5% , two group of curative effect differences has statistics significance ( p 〈 0.05 ). Two group of babies have not had the medicine untoward effect. Conclusion: The inflammation amber is rather auxiliary the treatment Mycoplasma pneumonia, can reduce baby's ill symptom, the curative effect is satisfied, is worth in clinical promoting.
出处
《求医问药(下半月刊)》
2011年第3期139-139,共1页
Seek Medical and Ask The Medicine
关键词
小儿支原体肺炎
炎琥宁
肺功能
临床疗效
Young child Mycoplasma pneumonia
Inflammation amber rather
Lung function
Clinical curative effect